Harmine


Beta-carboline reversible MAO-A inhibitor (DYRK1A inhibitor)

A beta-carboline alkaloid from Peganum harmala; a reversible MAO-A inhibitor and DYRK1A kinase inhibitor of interest in beta-cell biology.

Abstract

Harmine (7-methoxy-1-methyl-9H-pyrido[3,4-b]indole; CAS 442-51-3; molecular formula C13H12N2O; molecular weight 212.25) is a beta-carboline alkaloid from Peganum harmala and Banisteriopsis caapi. The compound is a reversible MAO-A inhibitor with similar selectivity profile to harmaline but with the additional well-characterized activity of DYRK1A kinase inhibition (IC50 approximately 30 nM). The DYRK1A activity has generated substantial interest in diabetes research: harmine and related DYRK1A inhibitors stimulate human pancreatic beta-cell proliferation in vitro and in vivo, a long-sought target for diabetes regenerative therapy. Phase 1 trials of derivatives are underway. Plasma half-life is approximately 1 to 3 hours. Used as a research probe for both ayahuasca pharmacology and beta-cell regenerative biology.

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.


Browse all monographs

Previous monograph
Next monograph